2 weeks Battle Of The Weight-Loss Behemoths: Eli Lilly Whomps Novo Nordisk Investor's Business Daily
Eli Lilly said Wednesday its obesity drug Zepbound spurred more weight loss than Novo Nordisk’s Wegovy in the first-ever head-to-head study.
The post Battle Of The Weight-Loss Behemoths: Eli Lilly Whomps Novo Nordisk appeared first on Investor's …